Radiation Therapy After Breast Cancer Surgery: When It's Needed

Immunotherapy can be added, and second-line or third-line chemotherapy regimens are available, including CDK4/6 inhibitors. Next-generation sequencing of the tumor helps identify which newer targeted drugs are likely to be effective for that specific patient.

This is largely psychological rather than driven by the disease itself, a kind of cancer phobia that sets in once the diagnosis is given, where the patient loses a sense of control over their own life and fears dying early or being treated inadequately. Educating patients about their specific disease and realistic treatment outcomes helps restore the sense that there is still a fight to be had, which improves how they cope.

Only in patients with a genetically determined risk, specifically those who test positive for BRCA1 or BRCA2 mutations. BRCA testing itself is only done when there is a family history of breast cancer.

Mortality in chemotherapy is a fairly rare event, and when it happens it is almost always due to bone marrow suppression. The key is giving chemotherapy under close supervision so that this suppression is caught early, since early detection is what actually prevents mortality.

Radiotherapy is used only when surgery is not possible. If chemotherapy shrinks the tumor enough that surgery becomes feasible, surgery should be done. Radiotherapy has very few indications in advanced disease, so a direct comparison between the two is not really meaningful in this setting.

Yes. Post-operative radiotherapy is required for essentially all patients who undergo breast conservation, with an additional boost dose delivered to the lumpectomy site.

When the tumor was larger, when lymph nodes were positive, or when the surgical margins came back positive. Any one of these three findings is sufficient to indicate post-operative radiotherapy.